Shanghai BravoBio Licenses China Rights to Rotavirus Vaccine

Published: Jun 28, 2013

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

by Richard Daverman, PhD

June 27, 2013 -- Shanghai BravoBio Co. has sub-licensed China rights to RotaShield®, an oral rotavirus vaccine that was developed by the International Medica Foundation of the US. The vaccine is the first that can be given to newborns, and it requires only two doses – at two days and two months. Other rotavirus vaccines can’t begin administration until the child is two months old. More details....

Help employers find you! Check out all the jobs and post your resume.

Back to news